Dimers of Aβ (amyloid β-protein) are believed to play an important role in Alzheimer's disease. In the absence of sufficient brain-derived dimers, we studied one of the only possible dimers that could be produced in vivo, [Aβ]DiY (dityrosine cross-linked Aβ). For comparison, we used the Aβ monomer and a design dimer cross-linked by replacement of Ser26 with cystine [AβS26C]2. We showed that similar to monomers, unaggregated dimers lack appreciable structure and fail to alter long-term potentiation. Importantly, dimers exhibit subtly different structural propensities from monomers and each other, and can self-associate to form larger assemblies. Although [Aβ]DiY and [AβS26C]2 have distinct aggregation pathways, they both populate bioactive soluble assemblies for longer durations than Aβ monomers. Our results indicate that the link between Aβ dimers and Alzheimer's disease results from the ability of dimers to further assemble and form synaptotoxic assemblies that persist for long periods of time.
Aβ dimers differ from monomers in structural propensity, aggregation paths and population of synaptotoxic assemblies
- Views Icon Views
- Share Icon Share
Tiernan T. O’Malley, Nur Alia Oktaviani, Dainan Zhang, Aleksey Lomakin, Brian O’Nuallain, Sara Linse, George B. Benedek, Michael J. Rowan, Frans A. A. Mulder, Dominic M. Walsh; Aβ dimers differ from monomers in structural propensity, aggregation paths and population of synaptotoxic assemblies. Biochem J 1 August 2014; 461 (3): 413–426. doi: https://doi.org/10.1042/BJ20140219
Download citation file: